Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2742 (LINC02742)
- Target
- LINC02742
- Molecular classification
- Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01
Overview
Long intergenic non-protein coding RNA 2742 (LINC02742) is a member of the long intergenic non-coding RNA (lincRNA) family, representing a class of RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes[1][3][7]. LincRNAs are involved in various gene regulatory mechanisms, including chromatin remodeling, transcriptional control, and post-transcriptional modulation. Although some lincRNAs are well-characterized with functions in cellular differentiation, gene expression regulation, and disease processes (especially cancer), there is currently no published evidence of LINC02742 acting as a therapeutic target, nor are there specific drugs, established mechanisms of action, or biomarker roles associated with it as of September 2025[1][3][5][7]. The scientific and clinical characterization of LINC02742 is limited, and its precise cellular roles remain unknown.
- Other names
- LINC02742long intergenic non-protein coding RNA 2742
02
Biological functions
Chromatin remodelingTranscription regulationRNA stabilizationEnhancer functionPotential post-transcriptional regulation
03
Disease associations
Potential involvement in cancer and other diseases is possible for lincRNAs as a class, but no specific disease role reported for LINC02742
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2742 (LINC02742).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2742 (LINC02742).